Evidence map›Paper›PMID 42164002›Full record

ArticleEJHaem2026

Transcranial Doppler Ultrasound Velocity Measurements in Children With Sickle Cell Disease in Kenya.

Catherine Mwalimu, Oscar Odhiambo, Elaine Mashisia, Teresa Mwanja, Allan Ade, Maria Vittoria De Vita, Katherine Oyieke, Pauline Samia, Fenella Kirkham, Samson Gwer

Erratum issuedAbstract read
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Catherine MwalimuDepartment of Paediatrics and Child Health Aga Khan University Hospital Nairobi Kenya.ORCID https://orcid.org/0009-0005-4877-881X
Oscar OdhiamboUbuntu Neurology Nairobi Kenya.
Elaine MashisiaUbuntu Neurology Nairobi Kenya.
Teresa MwanjaUbuntu Neurology Nairobi Kenya.
Allan AdeUbuntu Neurology Nairobi Kenya.
Maria Vittoria De VitaDepartment of Paediatrics and Child Health Ruaraka Uhai Neema Hospital Nairobi Kenya.
Katherine OyiekeDepartment of Paediatrics and Child Health Aga Khan University Hospital Nairobi Kenya.
Pauline SamiaDepartment of Paediatrics and Child Health Aga Khan University Hospital Nairobi Kenya.
Fenella KirkhamDevelopmental Neurosciences Department University College London London UK.
Samson GwerUbuntu Neurology Nairobi Kenya.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sickle cell disease (SCD) is the most common inherited haemoglobinopathy and poses a high public health burden in Sub-Saharan Africa. Children with sickle cell anaemia are at a highrisk of ischemic stroke, and transcranial Doppler (TCD) ultrasonography helps identify those at highest risk for primary stroke prevention. Objective: To determine the prevalence of abnormal cerebral blood flow velocity (CBFV) in children with SCD and describe CBFV in children without SCD. Methods: We conducted a two-component study comprising a retrospective review and a cross-sectional assessment. TCD measurements from 143 children with confirmed SCD aged 2-16 years were reviewed. In a cross-sectional arm, children without SCD aged 3-11 years ( Results: Among 143 children screened, all of whom were receiving hydroxyurea, 1.4% had high TCD velocities (≥ 200 cm/s), while 4.9% had low velocities (< 50 cm/s). TCD velocities were not associated with demographic/clinical characteristics or haemoglobin levels. Symmetric MCA flows with wide depth and velocity range variability were observed. In children without SCD, all MCA velocities were within the normal range (50-149 cm/s), showed right-left symmetry, declined with age, and were broadly similar by gender. Conclusion: The prevalence of abnormal TCD velocities was low in children with SCD receiving universal hydroxyurea. In children without SCD, MCA velocities were normal and declined with age, providing local reference values. The observed variability in CBFV supports continued annual TCD screening and repeat scans to confirm stroke-risk classification. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

cerebral blood flow velocitysickle cell diseasestroke preventiontranscranial Doppler

Identifiers

PMID42164002
PMCPMC13185219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.